|
COPS4 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7123968909516E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.36369999995212E-06 |
| Normal-vs-Stage2 |
1.338100E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
2.802200E-03 |
| Stage1-vs-Stage2 |
9.818000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
8.211200E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
8.122400E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.58000004377857E-10 |
| Normal-vs-AfricanAmerican |
3.437800E-01 |
| Normal-vs-Asian |
2.917500E-02 |
| Caucasian-vs-AfricanAmerican |
5.074000E-01 |
| Caucasian-vs-Asian |
9.494400E-01 |
| AfricanAmerican-vs-Asian |
6.641400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.015860E-04 |
| Normal-vs-Female |
4.9323000017587E-08 |
| Male-vs-Female |
1.078570E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.219400E-04 |
| Normal-vs-Extreme_Weight |
4.05930000000332E-05 |
| Normal-vs-Obese |
4.115600E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
6.325200E-01 |
| Normal_Weight-vs-Obese |
4.125400E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
6.805600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.685400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.997100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.28319999959103E-07 |
| Normal-vs-Age(81-100Yrs) |
4.947000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.866800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.137600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.117600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.733400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.844400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.561600E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
6.708300E-02 |
| Normal-vs-Grade 3 |
3.860300E-02 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
8.468600E-01 |
| Grade 2-vs-Grade 4 |
6.708300E-02 |
| Grade 3-vs-Grade 4 |
3.860300E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68379999837742E-08 |
| Normal-vs-N1 |
1.828440E-02 |
| N0-vs-N1 |
8.595600E-01 |
|
|
